Literature DB >> 20107087

Association of serotypes of Streptococcus pneumoniae with age in invasive pneumococcal disease.

Matthias Imöhl1, Ralf René Reinert, Christina Ocklenburg, Mark van der Linden.   

Abstract

A total of 7,764 isolates from patients with invasive pneumococcal disease (IPD) were collected from 1992 to June 2006. Data on serotypes were available for 5,022 isolates (64.7% of all invasive isolates). Some 54.0% of the isolates originated from adults >or=16 years of age, and 46.0% were from children <16 years of age. The leading serotypes were 14, 23F, 1, 6B, 7F, 3, and 4. The serotypes significantly more common in children were 14, 6B, 19F, and 18C, while among adults, serotypes 3 and 4 were predominant. Serotype 7F was statistically more prevalent among children <4 months old than among the other age groups. Among children aged >or=4 months and <1 year, serotype 19F occurred statistically more frequently; and among children aged >or=1 year to <5 years, serotypes 14, 6B, and 18C were overrepresented. The serotypes predominantly affecting patients younger than the remaining collective of patients were 14, 6B, 19F, and 18C, while patients with IPD caused by serotypes 3, 4, and 9V were older than the collective, on average.

Entities:  

Mesh:

Year:  2010        PMID: 20107087      PMCID: PMC2849605          DOI: 10.1128/JCM.01937-09

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  27 in total

1.  Characteristics of Isolates Streptococcus pneumoniae from Middle-Aged and Elderly Adults in Brazil: Capsular Serotypes and Antimicrobial Sensitivity to Invasive Infections.

Authors: 
Journal:  Braz J Infect Dis       Date:  1998-04       Impact factor: 1.949

2.  Illustration of pneumococcal polysaccharide capsule during adherence and invasion of epithelial cells.

Authors:  Sven Hammerschmidt; Sonja Wolff; Andreas Hocke; Simone Rosseau; Ellruth Müller; Manfred Rohde
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

3.  Capsular types and antibiotic susceptibility of Streptococcus pneumoniae isolated from patients with systemic infections in West Germany.

Authors:  A Kaufhold; R Lütticken; J Henrichsen
Journal:  Eur J Clin Microbiol       Date:  1987-12       Impact factor: 3.267

4.  Serotypes of Streptococcus pneumoniae blood culture isolates from adults in Franklin County, Ohio.

Authors:  J F Plouffe; S K Moore; R Davis; R R Facklam
Journal:  J Clin Microbiol       Date:  1994-06       Impact factor: 5.948

Review 5.  Pneumococcus: the first one hundred years.

Authors:  R Austrian
Journal:  Rev Infect Dis       Date:  1981 Mar-Apr

6.  Epidemiology of invasive and other pneumococcal disease in children in England and Wales 1996-1998.

Authors:  E Miller; P Waight; A Efstratiou; M Brisson; A Johnson; R George
Journal:  Acta Paediatr Suppl       Date:  2000-12

7.  Increased prevalence of pediatric pneumococcal serotypes in elderly adults.

Authors:  Daniel R Feikin; Keith P Klugman; Richard R Facklam; Elizabeth R Zell; Anne Schuchat; Cynthia G Whitney
Journal:  Clin Infect Dis       Date:  2005-07-11       Impact factor: 9.079

8.  Changing epidemiology of invasive pneumococcal disease in Canada, 1998-2007: update from the Calgary-area Streptococcus pneumoniae research (CASPER) study.

Authors:  James D Kellner; Otto G Vanderkooi; Judy MacDonald; Deirdre L Church; Gregory J Tyrrell; David W Scheifele
Journal:  Clin Infect Dis       Date:  2009-07-15       Impact factor: 9.079

9.  Adult invasive pneumococcal disease between 2003 and 2006 in North-Rhine Westphalia, Germany: serotype distribution before recommendation for general pneumococcal conjugate vaccination for children <2 years of age.

Authors:  M Imöhl; R R Reinert; M van der Linden
Journal:  Clin Microbiol Infect       Date:  2009-07-20       Impact factor: 8.067

10.  Invasive pneumococcal disease among adults: associations among serotypes, disease characteristics, and outcome.

Authors:  Angelique G S C Jansen; Gerwin D Rodenburg; Arie van der Ende; Loek van Alphen; Reinier H Veenhoven; Lodewijk Spanjaard; Elisabeth A M Sanders; Eelko Hak
Journal:  Clin Infect Dis       Date:  2009-07-15       Impact factor: 9.079

View more
  18 in total

1.  Comparison of transformation frequencies among selected Streptococcus pneumoniae serotypes.

Authors:  Moses L Joloba; Benson R Kidenya; David P Kateete; Fred A Katabazi; Julian K Muwanguzi; Benon B Asiimwe; Simon P Alarakol; Jessica L Nakavuma; Saralee Bajaksouzian; Anne Windau; Michael R Jacobs
Journal:  Int J Antimicrob Agents       Date:  2010-05-15       Impact factor: 5.283

2.  Serotype 3 is a common serotype causing invasive pneumococcal disease in children less than 5 years old, as identified by real-time PCR.

Authors:  L Selva; P Ciruela; C Esteva; M F de Sevilla; G Codina; S Hernandez; F Moraga; J J García-García; A Planes; F Coll; I Jordan; N Cardeñosa; J Batalla; L Salleras; A Dominguez; C Muñoz-Almagro
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-11-04       Impact factor: 3.267

3.  Changes in pneumococcal serotypes and antimicrobial resistance after introduction of the 13-valent conjugate vaccine in the United States.

Authors:  Sandra S Richter; Daniel J Diekema; Kristopher P Heilmann; Cassie L Dohrn; Fathollah Riahi; Gary V Doern
Journal:  Antimicrob Agents Chemother       Date:  2014-08-18       Impact factor: 5.191

4.  Estimation of the invasive disease potential of Streptococcus pneumoniae in children by the use of direct capsular typing in clinical specimens.

Authors:  E del Amo; L Selva; M F de Sevilla; P Ciruela; P Brotons; M Triviño; S Hernandez; J J Garcia-Garcia; Á Dominguez; C Muñoz-Almagro
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2014-11-21       Impact factor: 3.267

5.  Pneumococcal within-host diversity during colonization, transmission and treatment.

Authors:  Gerry Tonkin-Hill; Clare Ling; Chrispin Chaguza; Susannah J Salter; Pattaraporn Hinfonthong; Elissavet Nikolaou; Natalie Tate; Andrzej Pastusiak; Claudia Turner; Claire Chewapreecha; Simon D W Frost; Jukka Corander; Nicholas J Croucher; Paul Turner; Stephen D Bentley
Journal:  Nat Microbiol       Date:  2022-10-10       Impact factor: 30.964

6.  Invasive pneumococcal disease in infants younger than 90 days before and after introduction of PCV7.

Authors:  Liset Olarte; Krow Ampofo; Chris Stockmann; Edward O Mason; Judy A Daly; Andrew T Pavia; Carrie L Byington
Journal:  Pediatrics       Date:  2013-06-03       Impact factor: 7.124

7.  Macrolide susceptibility and serotype specific macrolide resistance of invasive isolates of Streptococcus pneumoniae in Germany from 1992 to 2008.

Authors:  Matthias Imöhl; Ralf René Reinert; Christina Mutscher; Mark van der Linden
Journal:  BMC Microbiol       Date:  2010-11-25       Impact factor: 3.605

8.  Mouse, but not human, ApoB-100 lipoprotein cholesterol is a potent innate inhibitor of Streptococcus pneumoniae pneumolysin.

Authors:  Kristin R Wade; Eileen M Hotze; David E Briles; Rodney K Tweten
Journal:  PLoS Pathog       Date:  2014-09-04       Impact factor: 6.823

9.  Epidemiology of Streptococcus pneumoniae serogroup 6 isolates from IPD in children and adults in Germany.

Authors:  Mark van der Linden; Nadine Winkel; Sharon Küntzel; Aron Farkas; Stephanie Russo Perniciaro; Ralf René Reinert; Matthias Imöhl
Journal:  PLoS One       Date:  2013-04-09       Impact factor: 3.240

10.  Pneumococcal serotypes before and after introduction of conjugate vaccines, United States, 1999-2011(1.).

Authors:  Sandra S Richter; Kristopher P Heilmann; Cassie L Dohrn; Fathollah Riahi; Daniel J Diekema; Gary V Doern
Journal:  Emerg Infect Dis       Date:  2013-07       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.